Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Shinjini Singh

Shinjini Singh

Shinjini Singh
Executive Editor
Senior Clinical Researcher
University Hospitals Seidman Cancer Center, USA


Shinjini Singh currently works at the Clinical Trials Center, Seidman Cancer Center, Cleveland Medical Center, University Hospitals, Cleveland, Ohio and previously worked as a Research Scientist in the Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas. She received her Ph.D. degree from the Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Her past research experience of about 9 years includes the study of parallel analysis including gene expression arrays, protein expression arrays and tissue arrays to refine the cancer diagnosis. Her broad range of experience also includes molecular biology techniques that can be harnessed for practical applications like caner diagnostics and therapeutics. She has published many research papers in peer-reviewed journals and book chapters in with world-renowned publishers like Springer production and Bentham Sciences. She has the ultimate accolades of being honorary editorial board member and reviewer in a number of highly reputed international cancer/life science journals

Research Interest

Anti Cancer Agents

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

arrow_upward arrow_upward